What is IVF's relative strength rating?

IVF ranks at the 54th percentile over 1 month, 11th percentile over 3 months, 3th percentile over 6 months, 2th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is IVF in?

IVF is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is IVF in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). IVF benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

IVF currently shows a 20-day average daily range (ADR%) of 13.3%, a 90-day beta versus the S&P 500 of -1.75. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does IVF have a seasonal pattern?

TickerStance computes IVF's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what IVF has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did IVF last report earnings?

IVF most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-14. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

INVO Fertility, Inc. Common Stock (IVF) · RS 3

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, INVO Fertility, Inc. Common Stock (IVF) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 27. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 13.3%, relative volume 0.05×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month11pctile

6 month3pctile

1 year2pctile

Classic4IBD pctile

LDR15leadership

0 of 5 lenses lit · avg RS pctile 7

✓ADR%13.3%✓A/DA!RVOL0.05×!$ Vol$10M

COMPUTED · AS OF 2026-08-24

Pattern read

IVF is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -16.8% / -76.6%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

54

3m

11

6m

3

1y

2

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

AAccum

RVOL todayvs 50d avg

0.05×

U/D ratiolast 50 sessions

11.22

Breakout volbreakout day vs 50d avg

-94%

50d avg $ volumeliquidity proxy

$10.0M

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

13.3%Elevated

ATR(14)14-day EMA

$0.21

ATR%ATR as % of close

20.22%

Beta vs SPY90d rolling

-1.75

1-ADR stoprisk from close $1.03

$0.89−13.3%

Fundamentals · IVF

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q2 · period end 2026-06-30

35

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,480 ranked stocks · Sector rank 40

View fundamental leadership map

Average

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

Turned profitable

−$0.42—

24 Q3

−$28.73—

24 Q4

−$12.53—

25 Q1

−$364.23—

25 Q2

−$39.40−9281%

25 Q3

$201.52Profit

25 Q4

−$3.38+73%

26 Q1

$0.35Profit

26 Q2

Latest Q EPS$0.35Turned profitable Profit

Revenue

Is revenue confirming?

YoY sales growth, last 8 quarters. Sales must back the earnings story.

Keeping up

+47%

24 Q3

+24%

24 Q4

+4%

25 Q1

+1%

25 Q2

+23%

25 Q3

−8%

25 Q4

+23%

26 Q1

+17%

26 Q2

Latest Q YoY+17%

Quality

Are margins expanding?

Operating margin unavailable

No comparable operating-income series in SEC facts.

TTM op margin-

Float

Share count: tailwind or headwind?

YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.

Buyback tailwind · −83.4% YoY

0.00B

24 Q4

0.00B

25 Q1

0.00B

25 Q2

0.02B

25 Q3

0.00B

26 Q4

0.00B

25 Q4

0.00B

26 Q1

0.00B

26 Q2

YoY common shares−83.4%

Reported figures from SEC filings. No analyst estimates or forward guidance.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
IVF
11RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

PEERS · Medical Equipment

Same industry, closest relative strength

4 peers · by RS6M

GCTKGlucoTrack, Inc. Common Stock4 TNONTenon Medical, Inc. Common Stock3 XAIRBeyond Air, Inc. Common Stock4 SNWVSANUWAVE Health, Inc. Common Stock3

§ Seasonality

10y · since 2025

Best monthJan on averageavg +82.04% · 100% win · n 1

Worst monthDec on averageavg -66.48% · 0% win · n 1

IVF monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	IVF Jan avg: 82.04% median: 82.04% win: 100% σ: 0.00% n: 1 2025-04-29 → 2026-07-31	IVF Feb avg: -30.68% median: -30.68% win: 0% σ: 0.00% n: 1 2025-04-29 → 2026-07-31	IVF Mar avg: -42.72% median: -42.72% win: 0% σ: 0.00% n: 1 2025-04-29 → 2026-07-31	IVF Apr avg: 2.07% median: 2.07% win: 50% σ: 46.61% n: 2 2025-04-29 → 2026-07-31	IVF May avg: -14.64% median: -14.64% win: 50% σ: 20.71% n: 2 2025-04-29 → 2026-07-31	IVF Jun avg: -23.44% median: -23.44% win: 50% σ: 34.65% n: 2 2025-04-29 → 2026-07-31	IVF Jul avg: -40.87% median: -40.87% win: 0% σ: 13.89% n: 2 2025-04-29 → 2026-07-31	IVF Aug avg: -47.26% median: -47.26% win: 0% σ: 0.00% n: 1 2025-04-29 → 2026-07-31 (current)	IVF Sep avg: -20.84% median: -20.84% win: 0% σ: 0.00% n: 1 2025-04-29 → 2026-07-31	IVF Oct avg: -28.86% median: -28.86% win: 0% σ: 0.00% n: 1 2025-04-29 → 2026-07-31	IVF Nov avg: -48.09% median: -48.09% win: 0% σ: 0.00% n: 1 2025-04-29 → 2026-07-31	IVF Dec avg: -66.48% median: -66.48% win: 0% σ: 0.00% n: 1 2025-04-29 → 2026-07-31

Public attention · IVF

Is the crowd watching?

64/ 100 · vs its own 90-day norm▲ 7 vs 7dRetail trap

Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryMedical Equipment

SIC3841

Float1.8Mshares

Shares out2.5Mshares

Market cap$2.6MNano Cap

FAQ

Frequently asked questions

What is IVF's relative strength rating?: IVF ranks at the 54th percentile over 1 month, 11th percentile over 3 months, 3th percentile over 6 months, 2th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is IVF in?: IVF is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is IVF in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). IVF benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is IVF?: IVF currently shows a 20-day average daily range (ADR%) of 13.3%, a 90-day beta versus the S&P 500 of -1.75. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does IVF have a seasonal pattern?: TickerStance computes IVF's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what IVF has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did IVF last report earnings?: IVF most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-14. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

INVO Fertility, Inc. Common Stock (IVF) — Stance & relative strength

IVF is not confirmed as a leader. 11 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

INVO Fertility, Inc. Common Stock (IVF) — Stance & relative strength

IVF is not confirmed as a leader. 11 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions